PremiumCompany AnnouncementsANGLE plc’s Parsortix System Unveils New Insights in Cancer Metastasis ANGLE plc Unveils Breakthrough in Dual CTC-DNA and ctDNA Analysis ANGLE plc Announces Breakthrough in Cancer Treatment via Parsortix System PremiumCompany AnnouncementsANGLE plc Advances Cancer Treatment with Dual Analysis ANGLE plc’s Breakthrough in Prostate Cancer CTC Profiling ANGLE plc’s Parsortix System Hits 100 Publications Milestone PremiumCompany AnnouncementsANGLE plc to Unveil Interim Results with Live Webcast ANGLE plc’s Parsortix System Gains FDA Nod ANGLE’s Parsortix Enhances Melanoma Mutation Detection